Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:TSRO

Tesaro (TSRO) Stock Price, News & Analysis

Tesaro logo

About Tesaro Stock (NASDAQ:TSRO)

Advanced Chart

Key Stats

Today's Range
$74.94
$74.97
50-Day Range
N/A
52-Week Range
$23.41
$75.16
Volume
1.19 million shs
Average Volume
1.97 million shs
Market Capitalization
$4.13 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TSRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tesaro and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TSRO Stock News Headlines

Hedge Fund - Ivory Capital (Investment Mgmt)
Biopharma Cred. Regulatory News
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.tc pixel
Gilbert H Kliman's Net Worth
Keval Desai's Net Worth
See More Headlines

TSRO Stock Analysis - Frequently Asked Questions

Tesaro, Inc. (NASDAQ:TSRO) issued its quarterly earnings data on Thursday, August, 2nd. The biopharmaceutical company reported ($3.04) EPS for the quarter, missing analysts' consensus estimates of ($2.66) by $0.38. The business's quarterly revenue was up 94.2% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tesaro investors own include NVIDIA (NVDA), Bristol Myers Squibb (BMY), Clovis Oncology (CLVS), Netflix (NFLX), Meta Platforms (META), Alibaba Group (BABA) and AutoZone (AZO).

Company Calendar

Last Earnings
8/02/2018
Today
8/26/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:TSRO
CIK
1491576
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($9.17)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$496.12 million
Net Margins
-295.67%
Pretax Margin
N/A
Return on Equity
-1,209.72%
Return on Assets
-83.34%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.40
Quick Ratio
2.83

Sales & Book Value

Annual Sales
$223.33 million
Price / Sales
18.48
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.58 per share
Price / Book
16.37

Miscellaneous

Outstanding Shares
55,050,000
Free Float
N/A
Market Cap
$4.13 billion
Optionable
Optionable
Beta
0.38
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:TSRO) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners